ArticleJournal of cancer research and clinical oncology2018

Isocitrate dehydrogenase 2 mutations correlate with leukemic transformation and are predicted by 2-hydroxyglutarate in myelodysplastic syndromes.

Peipei Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.